Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Asian J Androl ; 15(4): 533-8, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-23708457

RESUMO

Male factor infertility affects 30%-50% of infertile couples worldwide, and there is an increasing interest in the optimal management of these patients. In studies comparing double and single intrauterine insemination (IUI), a trend towards higher pregnancy rates in couples with male factor infertility was observed. Therefore, we set out to perform a meta-analysis to examine the superiority of double versus single IUI with the male partner's sperm in couples with male factor infertility. An odds ratio (OR) of 95% confidence intervals (CIs) was calculated for the pregnancy rate. Outcomes were analysed by using the Mantel-Haesel or DerSimonian-Laird model according to the heterogeneity of the results. Overall, five trials involving 1125 IUI cycles were included in the meta-analysis. There was a two-fold increase in pregnancies after a cycle with a double IUI compared with a cycle with a single IUI (OR: 2.0; 95% CI: 1.07-3.75; P<0.03). Nevertheless, this result was mainly attributed to the presence of a large trial that weighted as almost 50% in the overall analysis. Sensitivity analysis, excluding this large trial, revealed only a trend towards higher pregnancy rates among double IUI cycles (OR: 1.58; 95% CI: 0.59-4.21), but without statistical significance (P=0.20). Our systematic review highlights that the available evidence regarding the use of double IUI in couples with male factor infertility is fragmentary and weak. Although there may be a trend towards higher pregnancy rates when the number of IUIs per cycle is increased, further large and well-designed randomized trials are needed to provide solid evidence to guide current clinical practice.


Assuntos
Infertilidade Masculina/terapia , Inseminação Artificial/métodos , Taxa de Gravidez , Ensaios Clínicos como Assunto , Feminino , Humanos , Masculino , Gravidez
2.
Gynecol Endocrinol ; 29(3): 254-8, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23153029

RESUMO

Various ovarian substances regulate the secretion of gonadotrophins during the menstrual cycle, but there are still several unclarified issues. The aim of this study was to investigate the positive feedback effect of progesterone during the immediate period following ovariectomy. Experiments were performed in 12 normally cycling women (aged 39-49 years). Following abdominal hysterectomy plus bilateral ovariectomy performed on cycle day 3 (day 0), the women received either estradiol via skin patches (days 0-7, n = 6, group 1) or estradiol as above plus vaginal progesterone (days 1-7, n = 6, group 2). Serum estradiol values increased similarly in the two groups. After the operation, serum progesterone levels decreased significantly in group 1, while in group 2 they remained stable becoming higher than in group 1 (p < 0.05). An LH and an FSH surge occurred in group 2 with the values after the peak returning to the pre-surge baseline. In contrast, in group 1 LH and FSH levels following an initial decrease, increased gradually until the end of the experiment. These results demonstrate that, despite a variable response to estrogens, the positive feedback effect of progesterone remained intact immediately after ovariectomy in women. It is suggested that it is the combining action of estradiol and progesterone that can ensure the expression of a positive feedback mechanism in women.


Assuntos
Retroalimentação Fisiológica/efeitos dos fármacos , Hormônio Foliculoestimulante/metabolismo , Terapia de Reposição Hormonal , Sistema Hipotálamo-Hipofisário/efeitos dos fármacos , Hormônio Luteinizante/metabolismo , Ovariectomia/efeitos adversos , Progesterona/uso terapêutico , Administração Intravaginal , Adulto , Estradiol/administração & dosagem , Estradiol/sangue , Estradiol/farmacocinética , Estradiol/uso terapêutico , Feminino , Hormônio Foliculoestimulante/sangue , Géis , Humanos , Sistema Hipotálamo-Hipofisário/metabolismo , Histerectomia/efeitos adversos , Hormônio Luteinizante/sangue , Pessoa de Meia-Idade , Período Pós-Operatório , Progesterona/administração & dosagem , Progesterona/sangue , Progesterona/farmacocinética , Adesivo Transdérmico , Regulação para Cima/efeitos dos fármacos , Cremes, Espumas e Géis Vaginais
3.
Reprod Biol Endocrinol ; 9: 90, 2011 Jun 21.
Artigo em Inglês | MEDLINE | ID: mdl-21693039

RESUMO

Postmenopausal endometriosis is a rare clinical condition. The diagnosis and treatment of an endometriotic lesion in postmenopausal women is complicated. First line treatment choice should be surgical, given that there is a potential risk of malignancy. Medical treatment may be considered as second line or as an alternate first line treatment whenever surgery is contradicted and aims to alter the hormonal pathway leading to endometriosis progress. Different hormonal regimens have been administered to these patients, with conflicting however results. Aromatase inhibitors (AIs) represent one of the most recently used drugs for postmenopausal endometriosis. Clinical data for the use of (AIs) in postmenopausal patients is scarce. Up to date only 5 case reports are available regarding the use of these agents in postmenopausal women. Although definite conclusions may be premature, AIs appear to considerably improve patients' symptoms and reduce endometriotic lesions size. Nonetheless the subsequent induced reduction in estrogen production, leads to certain short-term and long-term adverse effects. Despite the limited available data, AIs appear to represent a new promising method which may improve symptoms and treat these patients, either as first line treatment, when surgery is contraindicated or as a second line for recurrences following surgical treatment. However, careful monitoring of patients' risk profile and further research regarding long-term effects and side-effects of these agents is essential prior implementing them in everyday clinical practice.


Assuntos
Inibidores da Aromatase/uso terapêutico , Endometriose/tratamento farmacológico , Pós-Menopausa , Idoso , Inibidores da Aromatase/efeitos adversos , Difosfonatos/uso terapêutico , Estrogênios/biossíntese , Feminino , Humanos , Osteoporose Pós-Menopausa/prevenção & controle
4.
BMJ ; 341: c7017, 2010 Dec 29.
Artigo em Inglês | MEDLINE | ID: mdl-21190966

RESUMO

OBJECTIVE: To examine whether treatment of periodontal disease with scaling and root planing during pregnancy is associated with a reduction in the preterm birth rate. DESIGN: Systematic review and meta-analysis of randomised controlled trials. DATA SOURCES: Cochrane Central Trials Registry, ISI Web of Science, Medline, and reference lists of relevant studies to July 2010; hand searches in key journals. STUDY SELECTION: Randomised controlled trials including pregnant women with documented periodontal disease randomised to either treatment with scaling and root planing or no treatment. DATA EXTRACTION: Data were extracted by two independent investigators, and a consensus was reached with the involvement a third. Methodological quality of the studies was assessed with the Cochrane's risk of bias tool, and trials were considered either high or low quality. The primary outcome was preterm birth (<37 weeks). Secondary outcomes were low birthweight infants (<2500 g), spontaneous abortions/stillbirths, and overall adverse pregnancy outcome (preterm birth <37 weeks and spontaneous abortions/stillbirths). RESULTS: 11 trials (with 6558 women) were included. Five trials were considered to be of high methodological quality (low risk of bias), whereas the rest were low quality (high or unclear risk of bias). Results among low and high quality trials were consistently diverse; low quality trials supported a beneficial effect of treatment, and high quality trials provided clear evidence that no such effect exists. Among high quality studies, treatment had no significant effect on the overall rate of preterm birth (odds ratio 1.15, 95% confidence interval 0.95 to 1.40; P=0.15). Furthermore, treatment did not reduce the rate of low birthweight infants (odds ratio 1.07, 0.85 to 1.36; P=0.55), spontaneous abortions/stillbirths (0.79, 0.51 to 1.22; P=0.28), or overall adverse pregnancy outcome (preterm births <37 weeks and spontaneous abortions/stillbirths) (1.09, 0.91 to 1.30; P=0.34). CONCLUSION: Treatment of periodontal disease with scaling and root planing cannot be considered to be an efficient way of reducing the incidence of preterm birth. Women may be advised to have periodical dental examinations during pregnancy to test their dental status and may have treatment for periodontal disease. However, they should be told that such treatment during pregnancy is unlikely to reduce the risk of preterm birth or low birthweight infants.


Assuntos
Raspagem Dentária , Doenças Periodontais/terapia , Nascimento Prematuro/prevenção & controle , Cuidado Pré-Natal/métodos , Aplainamento Radicular , Aborto Espontâneo/etiologia , Feminino , Humanos , Recém-Nascido de Baixo Peso , Recém-Nascido , Gravidez , Resultado da Gravidez , Viés de Publicação , Ensaios Clínicos Controlados Aleatórios como Assunto
6.
Ann Hepatol ; 7(3): 258-9, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18753996

RESUMO

Gallstone ileus is a rare but potentially serious complication of cholelithiasis. It is usually preceded by history of biliary symptoms. It usually occurs as a result of a large gallstone creating and passing through a cholecysto-enteric fistula. Most of the time, the stone will pass the GI tract without any problems, but large enough stones can cause obstruction. The two most common locations of impaction are the terminal ileum and the ileocaecal valve because of the anatomical small diameter and less active peristalsis. We present an unusual case of small bowel obstruction secondary to gallstone ileus 24 years after an open cholecystectomy.


Assuntos
Colecistectomia , Colelitíase/complicações , Cálculos Biliares/complicações , Íleus/etiologia , Idoso , Colelitíase/diagnóstico por imagem , Colelitíase/etiologia , Colelitíase/cirurgia , Cálculos Biliares/diagnóstico por imagem , Cálculos Biliares/cirurgia , Humanos , Íleus/diagnóstico por imagem , Íleus/cirurgia , Masculino , Fatores de Tempo , Tomografia Computadorizada por Raios X
7.
ANZ J Surg ; 76(9): 792-5, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16922900

RESUMO

BACKGROUND: Hepatic haemangiomas are congenital vascular malformations. They are the most common benign tumours of the liver and are often asymptomatic. Spontaneous or traumatic rupture, intratumoral bleeding, consumption coagulopathy and rapid growth are the mandatory surgical indications. We present our experience over the last 15 years with the surgical management of 15 liver haemangiomas to clarify the safety and effectiveness of this treatment. METHODS: There were 15 patients with hepatic haemangiomas who were surgically treated from 1990 to 2004. Indications for the operation were spontaneous or traumatic rupture, consumption coagulopathy, rapid growth, abdominal pain and uncertain diagnosis. Four of these lesions were located on the left lobe, nine on the right lobe; one lesion was located on the left and the right lobes and one on segments VII and VIII. Methods for diagnosis included ultrasonography, computed tomography scan, magnetic resonance imaging and selective hepatic arteriography or combinations of more than one technique. RESULTS: The procedures included five right-extended lobectomies, five right lobectomies, one left-extended lobectomy, two left lobectomies and two segmental resections. There was no death. The postoperative morbidity was minimal and was mainly correlated to two subdiaphragmatic collections, one intra-abdominal collection and one wound infection. The postoperative hospital stay was 12.7 days (range, 10-19 days). During the follow-up period, there was no recurrence. CONCLUSION: The resection of the hepatic haemangioma is safe. The indications for resection, however, should be carefully analysed before embarking on such a major operation.


Assuntos
Hemangioma/cirurgia , Neoplasias Hepáticas/cirurgia , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Fatores de Tempo
8.
J Hepatobiliary Pancreat Surg ; 10(5): 373-6, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-14598138

RESUMO

BACKGROUND: Pancreatic pseudocysts (PP) are considered to be one of the major complications of acute, chronic, and posttraumatic pancreatitis. Their treatment has always been a surgical challenge. Surgical treatment was for many years the only choice in the management of PP. However, technological development has provided new alternatives in their management. PURPOSE: The purpose of this retrospective study is to present our experience in the treatment of PP and to define the criteria for the selection of the treatment method. METHODS: During the past decade, 14 patients were treated for PP in our clinic. We classified our patients in three groups based on the treatment: A, conservative treatment; B, surgical treatment with internal drainage; and C, percutaneous external drainage (PED) under CT guidance. RESULTS: Conservative treatment had excellent outcome when it was applied in patients with small cysts. Internal drainage was always successful, but patients needed more hospitalization and showed increased morbidity compared to PED. PED was successful in two of three patients. CONCLUSIONS: Conservative treatment is a good choice for small asymptomatic cysts, particularly for patients who are poor candidates for operation. Internal drainage is a good method of treatment and should be used as the first choice by experienced surgeons. Finally, PED is a good first choice for patients with a unilocular cyst and contraindications for surgery.


Assuntos
Procedimentos Cirúrgicos do Sistema Digestório/métodos , Drenagem/métodos , Pseudocisto Pancreático/terapia , Idoso , Idoso de 80 Anos ou mais , Cateterismo/métodos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Pseudocisto Pancreático/cirurgia , Seleção de Pacientes , Estudos Retrospectivos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA